Newsroom | 4508 results

SAN MATEO, Calif.--(BUSINESS WIRE)--Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed universally in medicine, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its handheld robotic system, Focalist™. The novel system is designed to simplify and enhance the precision of ultrasound-guided needle placement — a technically demanding procedure performed across many specialties and care settings. The co...

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the appointments of Elaine Iuanow, MD, as Chief Medical Officer (“CMO”) and Kim Du as Senior Director of Clinical Operations. These additions to the leadership team significantly enhance the Company’s medical and clinical capabilities as QTI expands its clinical studies as well as the...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced the appointment of Rachael Brake, Ph.D., as chief scientific officer. Dr. Brake brings more than 20 years of experience in the biopharmaceutical industry building and leading cross functional teams across basic and applied research, c...

DEERFIELD BEACH, Fla.--(BUSINESS WIRE)--Premier Radiology Services Acquires MetisMD, Expanding Teleradiology Capabilities and Subspecialty Expertise...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FUJIFILM Pharmaceuticals U.S.A., Inc., drug development center and a leading provider of Contract Development and Manufacturing Organization (CDMO) services for drug delivery system (DDS) technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Fujifilm’s FF-10832 — an investigational liposomal formulation of gemcitabine — for the treatment of biliary tract cancer (BTC). Phase 1 study (NCT03440450) r...

BOSTON--(BUSINESS WIRE)--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has named Dr. Robert “Bob” Pelberg as its new senior vice president of medical affairs. A highly accomplished cardiologist and nationally recognized expert in cardiovascular computed tomography angiography (CCTA), Dr. Pelberg brings to Elucid decades of clinical experience and a deep understanding of advanc...

DALLAS--(BUSINESS WIRE)--IKS Health, a global leader in care enablement solutions supporting clinicians, staff and patients throughout the care journey, is pleased to announce a transformative expansion of its partnership with Western Washington Medical Group (WWMG), a leading independent multispecialty healthcare organization in Washington state. IKS Health will make a strategic investment in a newly established management services organization (MSO) that will oversee all nonclinical operation...

DALLAS--(BUSINESS WIRE)--CIVIE, a leading provider of cloud-native radiology workflow solutions, and national health system Prime Healthcare today announce a strategic partnership to support and enhance medical imaging operations in eight recently acquired Illinois hospitals. This collaboration marks a significant milestone in the modernization and integration of radiology services for Prime Healthcare’s expanded footprint in the region. Using CIVIE’s recently announced platform, RadPod, Prime...

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025 to all shareholders of record as of July 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled sol...

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Ibn Sina Medical Center will become the first hospital in Morocco, and the first in Africa, to introduce the cutting-edge ZAP-X® Gyroscopic Radiosurgery® platform. This innovative non-invasive surgical robotics system is poised to transform brain cancer treatment across the region. Located in Casablanca, Ibn Sina Medical Center is a state-of-the-art facili...